Clinical Development & Late Stage Research

UBC - February 21, 2013
In a recent posting, we provided the Top 10 Reasons to Conduct Late Phase Research.  Focused and strategic peri and postapproval research, culminating in definitive evidence of product value, can make a significant impact on...
Annette Stemhagen, DrPH, FISPE, Senior Vice President, Safety, Epidemiology, Registries, & Risk Management - February 12, 2013
Manufacturers of pharmaceutical or biotech products or medical devices understand that the regulatory approval of their product is not the final hurdle.  Instead, it’s the beginning of a new set of challenges, requiring strategic...
UBC - February 08, 2013
The third annual Summit for Clinical Operations Executives (SCOPE) kicked off in Miami, Florida, this week, and UBC came asking the tough questions and proposing innovative strategies. Abbe Steel, VP of Patient and Physician Services...
UBC - January 29, 2013
Join us at the Cambridge Healthtech Institute's (CHI) Summit for Clinical Ops Executives (SCOPE) 2013.  UBC speakers will present perspectives and research on the latest recruitment and retention topics driving clinical...

Pages